Carregant...

A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability

Gemcitabine (Gem) is a standard first-line treatment for pancreatic cancer (PC). However, its chemotherapeutic efficacy is hampered by various limitations such as short half-life, metabolic inactivation, and lack of tumor localizing. We previously synthesized a lipophilic Gem derivative (Gem formyl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Pharmacol Sin
Autors principals: Li, Pei-wen, Luo, Shi, Xiao, Lin-yu, Tian, Bo-le, Wang, Li, Zhang, Zhi-rong, Zeng, Ying-chun
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6888841/
https://ncbi.nlm.nih.gov/pubmed/31015736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-019-0227-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!